M. Alakloby, Omar
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
15.06.2017
Syneron Candela’s PicoWay picosecond laser now with three wavelengths and resolve fractional
PicoWay® picosecond laser received U.S. Food and Drug Administration (FDA) clearance for a new ultra-short 785 nm wavelength, making it the third FDA cleared wavelength for PicoWay. The new ultra-short […]
21.09.2016
Cynosure Receives Approval to Market SculpSure® in South Korea
“MFDS approval of SculpSure is another major step in our international growth strategy for this breakthrough non-invasive fat-reduction treatment,” said Cynosure President and Chief Executive Officer Michael Davin. “As one […]